Ventus Therapeutics

Ventus Therapeutics

Ventus Therapeutics

Ventus is a newly established venture-backed biotech company pursuing small molecule therapeutics targeting key innate immune pathways for numerous auto-immune and auto-inflammatory diseases.
Raised
$60M
Follow us
Latest funding
$60,000,000
Venture capital (Series A) - 2020
Versant Ventures GV
Team Size
1–10
Employees
Location
Headquarters
$60,000,000 Venture capital (Series A)
FinSMEs

Ventus Therapeutics Raises $60M in Series A Funding